Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,586 across all filing types
Latest filing 2015-07-09 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2015-07-09 English
4 Filing
Director's Dealing
2015-07-09 English
4 Filing
Director's Dealing
2015-07-09 English
4 Filing
Director's Dealing
2015-07-09 English
4 Filing
Director's Dealing
2015-07-07 English
424B4 Filing
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for an initial public offering (IPO) of common stock by Natera, Inc., including information about the offering size, price, underwriting, risk factors, business overview, and financial data. It is not a financial report like an annual or quarterly report, nor is it a management discussion or earnings release. It is a registration document filed pursuant to SEC rules (Rule 424(b)(4)) related to capital raising. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through the IPO prospectus.
2015-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.